These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 1244208)

  • 21. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 24. Complement components and activation in primary biliary cirrhosis.
    Lindgren S; Laurell AB; Eriksson S
    Hepatology; 1984; 4(1):9-14. PubMed ID: 6420306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activation mechanism and reaction process of the complement system--the classical pathway].
    Sakai K; Yasuda M; Tomooka K; Nobunaga M
    Nihon Rinsho; 1979 May; 37(5):943-55. PubMed ID: 381725
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of intraocular lenses on complement levels in human serum.
    Mondino BJ; Rao H
    Acta Ophthalmol (Copenh); 1983 Feb; 61(1):76-84. PubMed ID: 6407275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the complement system by antibody-antigen complexes: the classical pathway.
    Porter RR; Reid KB
    Adv Protein Chem; 1979; 33():1-71. PubMed ID: 396780
    [No Abstract]   [Full Text] [Related]  

  • 28. Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis.
    Kim Y; Friend PS; Dresner IG; Yunis EJ; Michael AF
    Am J Med; 1977 May; 62(5):765-71. PubMed ID: 860727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of C1 subcomponents in chronic urticaria and angioedema.
    Laurell AB; Mårtensson U; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1977; 54(5):434-42. PubMed ID: 885628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 31. Biosynthesis of complement.
    Colten HR
    Adv Immunol; 1976; 22():67-118. PubMed ID: 769502
    [No Abstract]   [Full Text] [Related]  

  • 32. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
    Nagasawa S; Stroud RM
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
    Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
    Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
    Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
    Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of C1s, C1r and properdin in the initiation of the C3b-dependent feedback mechanism of the complement system.
    Johnson U
    Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):73-8. PubMed ID: 696332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative requirements for C3 to induce Forssman systemic shock and cutaneous hemorrhagic vasculitis in guinea pigs.
    Newman S; Glovsky MM; Ghekiere L; Alenty A
    J Allergy Clin Immunol; 1977 Apr; 59(4):327-33. PubMed ID: 850022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of anesthesia, surgery and inflammation upon host defense mechanisms. I. Effects upon the complement system.
    Schutte M; DiCamelli R; Murphy P; Sadove M; Gewurz H
    Int Arch Allergy Appl Immunol; 1975; 48(5):706-20. PubMed ID: 805770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics of the complement system.
    Alper CA; Rosen FS
    Adv Hum Genet; 1976; 7():141-88. PubMed ID: 827931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.